Occupational Hazards and Skin Cancer: Why Dermatologists Must Lead on Outdoor Worker Protection Have you read the latest review from the Journal of Drugs in Dermatology examining the hidden skin…
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Robert Adler BA, one of the co-authors for Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors…
From the JDD Vault: Case Report on Post-COVID-19 Vaccine Photodistributed Hyperpigmentation Cutaneous reactions and rare dermatologic manifestations linked to COVID-19 vaccination remain a trending topic of discussion among clinicians. In…
Explore engaging Video Abstracts where leading dermatologists and researchers break down breakthrough dermatology data in their own words Staying current on clinical breakthroughs is essential, which is why JDD created…
Guest: Dr. Jon Zippin What happens when two longtime friends, dermatologists, and self-proclaimed science nerds get together to talk about pigment? Well, this one time, at band cAMP…. Anyway, in…
Comparing Targeted Systemic Therapies and Incident Psoriatic Arthritis Risk in Psoriasis Patients Have you read this article from the JDD? For dermatology providers managing complex psoriasis cases, predicting and mitigating…
Optimizing Atopic Dermatitis Outcomes: Nordic Expert Panel Insights on Emollient Selection and Treatment Concordance Check out this groundbreaking publication featured in the Journal of Drugs in Dermatology. Managing chronic atopic…
Bridging the Evidence Gap in Skin of Color Hyperpigmentation This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician should have on their…
Pigmentary disorders, including cutaneous hyperpigmentation, are among the most common dermatologic diagnoses in individuals with SOC, particularly individuals with African, Asian, or Hispanic heritage. The principal hyperpigmentation conditions include melasma, post-inflammatory…
Protecting the Pediatric Skin Barrier: Expert Consensus on Environmental Triggers and Early Intervention This is a must-read article from JDD for clinicians managing pediatric skin health. Atopic dermatitis frequently begins in…
From iron oxides to depigmenting agents, how new research is changing tone correction Unlocking clear skin is a constant goal for patients, which is why hyperpigmentation research routinely tops JDD…
Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…